Johnson & Johnson closes $2bn LifeScan sale
Johnson & Johnson (J&J) has closed the $2.1billion sale of its LifeScan blood glucose monitoring subsidiary to private equity player Platinum Equity. The sale is part of the
Johnson & Johnson (J&J) has closed the $2.1billion sale of its LifeScan blood glucose monitoring subsidiary to private equity player Platinum Equity. The sale is part of the
OneTouch Verio Flex meter The OneTouch Verio Flex meter is aimed at diabetics on insulin. It can automatically lett you know if your current result